This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation

Tuesday, November 19, 2013

Submitted by


Source Name: New England Journal of Medicine


MA Acker and others for the CTSN

251 pts with severe ischemic MR were randomized to MV repair or chordal-sparing MV replacement.  The end point was LVESVI at 12 mos.  LVESVI and mortality were similar between the groups at follow-up.  Recurrent MR was more common in the repair group (32.6% vs 2.3%).  Other outcomes including major adverse events and QOL were similar between the groups.

Add comment

Log in or register to post comments